Skip to main content

Table 2 Baseline demographic and clinical characteristics of participants

From: Transdiagnostic efficacy of a group exercise intervention for outpatients with heterogenous psychiatric disorders: a randomized controlled trial

 

Intervention Group

Control Group

Intervention Group Compared With Control Group (N = 72)

(N = 36)

(N = 36)

Measure

N

%

N

%

χ2

df

p

Female

25

69.4

27

75.0

0.28

1

.599

Married or partnered

25

69.4

24

66.7

0.06

1

.801

High school

31

86.1

25

69.4

2.89

1

.089

Employmenta

33

94.3

31

88.6

  

.673h

Diagnosis

      

.866h

 Depressive disorders (single)b

13

36.1

11

30.6

   

 Depressive disorders (comorbid with anxiety disorders)c

10

27.8

13

36.1

   

 Panic disorder

2

5.6

2

5.6

   

 Social anxiety disorder

2

5.6

2

5.6

   

 Specific anxiety disorder

2

5.6

0

0.0

   

 Generalized anxiety disorder

1

2.8

0

0.0

   

 Agoraphobia

1

2.8

1

2.8

   

 Obsessive-compulsive disorder

0

0.0

0

0.0

   

 Obsessive-compulsive disorder and social anxiety disorder

0

0.0

2

5.6

   

 Post-traumatic stress disorder

1

2.8

2

5.6

   

 Primary insomnia

3

8.3

3

8.3

   

 Attention deficit hyperactivity disorder

1

2.8

0

0.0

   

Clinically raised symptoms (SCL-90-R, PSQI)

36

100.0

34

94.1

  

.493h

 Depressiond, anxietyd, insomniae

21

58.3

17

47.2

0.89

1

.345

Receiving psychiatric drugsf

18

50.0

20

57.1

0.36

1

.546

Dropout

7

19.4

14

38.9

3.29

1

.070

Treatment changeg

3

8.3

9

25.0

  

.111h

 

Mean

SD

Mean

SD

t

df

p

Age (years)

37.33

14.23

34.33

12.39

0.95

68.69

.343

Global Severity Index (SCL-90-R)

1.06

0.63

1.02

0.61

0.27

69.91

.790

Sleep Quality (PSQI)e

9.67

3.66

8.62

3.15

1.28

68.04

.204

Latency pre-treatment – initiation (days)

21.94

17.21

24.36

26.44

−0.46

60.15

.648

  1. Note. SCL-90-R Symptom Checklist-90-Revised, PSQI Pittsburgh Sleep Quality Index
  2. a For employment, the number of participants was n = 35 for the intervention group and n = 35 for the control group because of incomplete data at pre-treatment assessment.
  3. b Depressive disorders (single) includes all participants diagnosed with a single depressive disorder.
  4. c Depressive disorders (comorbid with anxiety disorders) includes all participants diagnosed with depressive disorder and comorbid anxiety disorders.
  5. d Depression and anxiety levels were classified as clinically raised when t-values of the sub-scales depression and anxiety of the SCL-90-R were greater or equal to 60 (reference group: healthy men, aged between 35 and 44).
  6. e Symptoms of insomnia were classified as clinically raised when the cut-off value of five of the total sum score of the PSQI were reached. For clinically raised symptoms and sleep quality, the number of participants was 36 for the intervention group and 35 for the control group because of incomplete data at pre-treatment assessment on the PSQI.
  7. f For receiving psychiatric drugs, the number of participants was n = 36 for the intervention group and n = 35 for the control group because of incomplete data at pre-treatment assessment.
  8. g Treatment change is defined as the start of psychotherapy, inpatient treatment or psychopharmacological change.
  9. h Fisher’s exact test was used as a replacement for the chi-square test because the frequency of one or more cells was less than 5
Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us